CIAS
ARKG icon

Capital Investment Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Capital Investment Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$29 – 1208
2025
Q4 		$29 Sell
1
-351
-100% -$10.5K ﹤0.01% 1164
2025
Q3 		$9.78K Buy
+352
New +$8.89K ﹤0.01% 966
2024
Q3 		– Sell
-800
Closed -$18.8K – 983
2024
Q2 		$18.8K Hold
800
– – ﹤0.01% 773
2024
Q1 		$23K Hold
800
– – ﹤0.01% 749
2023
Q4 		$26.2K Sell
800
-406
-34% -$11K ﹤0.01% 749
2023
Q3 		$33.6K Sell
1,206
-1
-0.1% -$33 ﹤0.01% 677
2023
Q2 		$41.1K Hold
1,207
– – ﹤0.01% 624
2023
Q1 		$36.3K Hold
1,207
– – ﹤0.01% 626
2022
Q4 		$34.1K Buy
1,207
+400
+50% +$12.7K ﹤0.01% 652
2022
Q3 		$27K Buy
+807
New +$29.6K ﹤0.01% 621
2022
Q2 		– Sell
-1,940
Closed -$89K – 820
2022
Q1 		$89K Sell
1,940
-233
-11% -$11.1K 0.01% 579
2021
Q4 		$133K Buy
+2,173
New +$150K 0.02% 522

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Capital Investment Advisory Services's ARKG Position: Q1 2026 in Review

Capital Investment Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 1 share — an estimated $29 sold.

Capital Investment Advisory Services first reported a position in ARKG in Q4 2021 and held it in 12 quarters. The position peaked at $133K in Q4 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Capital Investment Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1 ARK Genomic Revolution ETF share in Q1 2026, an estimated $29.
  • Capital Investment Advisory Services first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 12 quarters.
  • Capital Investment Advisory Services's ARK Genomic Revolution ETF position peaked at $133K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Capital Investment Advisory Services's 13F filing for Q1 2026, filed 5 May 2026.